Please provide your email address to receive an email when new articles are posted on . Atrial fibrillation is common, affecting approximately 5.2 million patients in 2010 in the United States, and ...
Dofetilide is a class III antiarrhythmic drug that is used for maintenance of sinus rhythm in patients with atrial fibrillation. Dofetilide blocks potassium channels in phase 3 of the action potential ...
FDA's requirements for the use of dofetilide are described, and one hospital's strategy for meeting the requirements is discussed. Dofetilide is a specific class III antiarrhythmic agent approved for ...
For dofetilide to be available at any institution, three FDA requirements must be fulfilled. First, the institution must complete a staff education process and submit an Education Confirmation Form ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results